The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology · 2026
The Clinical Effect of Endoscopic Mucosal Needle Aspiration Combined with Anhydrous Alcohol in the Treatment of Pneumatosis Cystoides Intestinalis.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Yang Tingxu, Feng Wenjuan, Ma Yan, Wang Haixia
Аннотация
BACKGROUND/AIMS: To evaluate the clinical efficacy and safety of endoscopic mucosal needle aspiration combined with intracapsular anhydrous alcohol injection for colonic pneumatosis cystoides intestinalis (PCI).
MATERIALS AND METHODS: In this single-center, quasi-randomized comparative study, 86 patients diagnosed with colonic PCI and treated between April 2021 and April 2023 were allocated to a control group (needle aspiration alone, n = 43) or an observation group (needle aspiration plus alcohol injection, n = 43). Therapeutic efficacy, recurrence rate, complications, and postoperative satisfaction were compared between the two groups.
RESULTS: No immediate or short-term complications were observed, including bleeding, perforation, obstruction, or infection. Longer follow-up is needed to assess the late adverse events. At 3 months after treatment, the overall efficacy rate was significantly higher in the observation group (100%, 43/43) than in the control group (88.37%, 38/43; χ2 = 5.309, P = .021). No recurrence was observed in the observation group, whereas 5 cases (11.63%) recurred in the control group (χ2 = 5.309, P = .021). Furthermore, postoperative satisfaction was markedly higher in the observation group (95.35%) compared with the control group (79.07%).
CONCLUSION: Endoscopic mucosal needle aspiration combined with intracapsular anhydrous alcohol injection was technically feasible. No immediate or short-term complications were observed. These findings suggest potential short-term benefit, but larger, multicenter studies with longer follow-up are needed to confirm effectiveness and late adverse events.
MATERIALS AND METHODS: In this single-center, quasi-randomized comparative study, 86 patients diagnosed with colonic PCI and treated between April 2021 and April 2023 were allocated to a control group (needle aspiration alone, n = 43) or an observation group (needle aspiration plus alcohol injection, n = 43). Therapeutic efficacy, recurrence rate, complications, and postoperative satisfaction were compared between the two groups.
RESULTS: No immediate or short-term complications were observed, including bleeding, perforation, obstruction, or infection. Longer follow-up is needed to assess the late adverse events. At 3 months after treatment, the overall efficacy rate was significantly higher in the observation group (100%, 43/43) than in the control group (88.37%, 38/43; χ2 = 5.309, P = .021). No recurrence was observed in the observation group, whereas 5 cases (11.63%) recurred in the control group (χ2 = 5.309, P = .021). Furthermore, postoperative satisfaction was markedly higher in the observation group (95.35%) compared with the control group (79.07%).
CONCLUSION: Endoscopic mucosal needle aspiration combined with intracapsular anhydrous alcohol injection was technically feasible. No immediate or short-term complications were observed. These findings suggest potential short-term benefit, but larger, multicenter studies with longer follow-up are needed to confirm effectiveness and late adverse events.